Paul Appelbaum, MD: What to Warn Patients When Prescribing Psychedelics in the Future
In an interview, Paul Appelbaum, MD, discussed issues clinicians will need to bring up to their patients if the FDA approves a psychedelic-assisted therapy.
Stay updated with breaking news from Psychedelic Compounds. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In an interview, Paul Appelbaum, MD, discussed issues clinicians will need to bring up to their patients if the FDA approves a psychedelic-assisted therapy.
Have you ever wondered how psychedelic mushrooms developed their magical properties? Read on to find how.
VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”),...
VANCOUVER, British Columbia, Jan. 21, 2022 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL ), (OTC: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU ) (“ Core One…
Accredited Investor email list Some investment opportunities are limited to accredited investors. Whether you are an accredited investor or not depends on where you live and other criteria. For full details go to https://investingnews.com/accredited-investor-definition/ or search for "accredited investor" in the search bar above. By completing this form, you are giving consent to receive communication from Silo Wellness using the contact information you provide. And remember you can unsubscribe at any time. Silo Wellness’ Management Team & Board of Directors Douglas Gordon — CEO (J...